Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab (Q36804893)
Jump to navigation
Jump to search
scientific article published on 6 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab |
scientific article published on 6 March 2013 |
Statements
1 reference
Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab (English)
1 reference
Yingmiao Liu
1 reference
Mark D Starr
1 reference
Anuradha Bulusu
1 reference
Herbert Pang
1 reference
Nan Soon Wong
1 reference
Wanda Honeycutt
1 reference
Anthony Amara
1 reference
Herbert I Hurwitz
1 reference
Andrew B Nixon
1 reference
6 March 2013
1 reference
1 reference
234-242
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference